Journal of Neurology and Neurorehabilitation Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Opinion Article - Journal of Neurology and Neurorehabilitation Research (2025) Volume 10, Issue 3

Cognitive Rehabilitation and Neural Network Modulation in Early-Stage Alzheimer�s Disease Patients

Luis Mendes*

Department of Neurophysiology, University of São Paulo, Brazil.

*Corresponding Author:
Luis Mendes
Department of Neurophysiology
University of São Paulo, Brazil
E-mail: l.mendes@usp.br

Received: 03-Jul-2025, Manuscript No. JNNR-25-171936; Editor assigned: 04-Jul-2025, PreQC No. JNNR-25-1719365(PQ); Reviewed: 18-Jul-2025, QC No JNNR-25-1719365; Revised: 21-Jul-2025, Manuscript No. JNNR-25-1719365(R); Published: 28-Jul-2025, DOI:10.35841/ aajnnr -10.3.264

Citation: Mendes L. Cognitive rehabilitation and neural network modulation in early-stage alzheimer’s disease patients. J Neurol Neurorehab Res. 2025;10(3):264.

Introduction

Alzheimer’s disease (AD) represents a progressive neurodegenerative condition characterized by memory impairment, executive dysfunction, and gradual loss of independence. Early interventions targeting cognitive decline are critical to maintaining functional abilities and slowing disease progression. Neurorehabilitation approaches aim to engage residual cognitive networks through structured cognitive training, environmental enrichment, and compensatory strategies. Functional neuroimaging studies have demonstrated that even in early-stage AD, the brain retains plasticity potential, allowing for targeted interventions to reinforce neural connectivity and cognitive performance [1].

Cognitive rehabilitation programs emphasize personalized, task-specific exercises that stimulate attention, memory, language, and problem-solving skills. Techniques such as spaced retrieval, errorless learning, and computerized cognitive training facilitate activation of prefrontal and hippocampal circuits, reinforcing synaptic connections. These interventions are often combined with social and occupational activities to maximize engagement and motivation. Evidence suggests that repeated practice and consistent reinforcement strengthen residual neural pathways, potentially delaying functional deterioration [2].

Neurophysiological mechanisms underlying rehabilitation-induced improvements involve synaptic potentiation and network reorganization. In patients with early AD, compensatory recruitment of bilateral cortical regions has been observed during cognitive tasks, reflecting adaptive plasticity. Non-invasive brain stimulation methods, including transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), have emerged as adjunctive tools to enhance network excitability and reinforce cognitive training outcomes. These techniques modulate cortical excitability, facilitating task-related neural activity and promoting functional recovery [3].

Pharmacological interventions also complement cognitive rehabilitation by optimizing neurotransmitter systems implicated in learning and memory. Cholinesterase inhibitors and NMDA receptor modulators enhance synaptic transmission within hippocampal and cortical networks, improving responsiveness to rehabilitation exercises. Integrating pharmacotherapy with behavioral and neurostimulation approaches may produce synergistic effects, enhancing neuroplasticity and functional outcomes in early-stage AD patients. Furthermore, lifestyle factors such as physical activity, nutrition, and social engagement play a pivotal role in supporting cognitive resilience and maximizing rehabilitation benefits [4].

Challenges remain in translating laboratory findings into clinical practice, particularly regarding patient heterogeneity, disease severity, and adherence to long-term programs. Monitoring neural and cognitive responses using neuroimaging and electrophysiological measures can inform individualized rehabilitation plans. Future directions emphasize precision neurorehabilitation, wherein interventions are tailored to each patient’s neural profile, optimizing outcomes and quality of life. Such integrative approaches are increasingly recognized as essential components of comprehensive care in Alzheimer’s disease [5].

Conclusion

Cognitive rehabilitation in early-stage Alzheimer’s disease harnesses the brain’s residual plasticity to slow functional decline and enhance quality of life. Combining task-specific exercises, neurostimulation, pharmacological support, and lifestyle interventions offers a multi-faceted strategy to reinforce neural networks. Continued research and individualized approaches will be key to optimizing neurorehabilitation outcomes for this growing patient population.

References

  1. Baborie A, Griffiths TD, Jaros E, et al. Pathological correlates of frontotemporal lobar degeneration in the elderly. Acta Neuropathol. 2011;121:365-71.

    2. Indexed at, Google Scholar, Cross Ref

  2. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in Progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442:916-19.

    3. Indexed at, Google Scholar, Cross Ref

  3. Caselli RJ, Windebank AJ, Petersen RC, et al. Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol. 1993;33:200-07.

    4. Indexed at, Google Scholar, Cross Ref

  4. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC Hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245-56.

    5. Indexed at, Google Scholar, Cross Ref

  5. Josephs KA, Hodges JR, Snowden JS, et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011;122:137-53.

    6. Indexed at, Google Scholar, Cross Ref

Get the App